Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Raffi

Showing results (191-200 of 224) with videos related to

Pageof 23
Sort By:
AIDS (London, England)|October 29, 1998
Opportunistic infections occurring during highly active antiretroviral treatmentC Michelet, C Arvieux, C François, et al.
The Journal of Antimicrobial Chemotherapy|June 8, 2014
Switching from tenofovir/emtricitabine and nevirapine to a tenofovir/emtricitabine/rilpivirine single-tablet regimen in virologically suppressed, HIV-1-infected subjectsC Allavena, E Dailly, V Reliquet, et al.
AIDS (London, England)|February 1, 1997
A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. The BIOTOXO Study GroupF Raffi, J P Aboulker, C Michelet, et al.
International Journal of STD & AIDS|December 22, 2012
Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescriptionV Colombie, S Pugliese-Wehrlen, S Deuffic-Burban, et al.
L'Encephale|November 14, 2006
[Health related quality of life and lipodystrophy syndrome among HIV-infected patients]M Préau, A-D Bouhnik, B Spire, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudineC Michelet, E Bellissant, A Ruffault, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patientsC Michelet, A Ruffault, V Sébille, et al.
Journal of Virological Methods|October 19, 2017
Interest of proviral HIV-1 DNA genotypic resistance testing in virologically suppressed patients candidate for maintenance therapyC Allavena, A Rodallec, A Leplat, et al.
Medecine Et Maladies Infectieuses|April 7, 2009
[Epidemiology of candidemia: a one-year prospective observational study in the west of France]J-P Talarmin, D Boutoille, P Tattevin, et al.
Sexually Transmitted Infections|October 19, 2021
Risk factors for HIV infection among men who have sex with men in the ANRS IPERGAY PrEP trialJulien Gras, Marine Pillet, Guillemette Antoni, et al.
Pageof 23

Showing results (191-200 of 224) with videos related to

Sort By:
Pageof 23
AIDS (London, England)|October 29, 1998
Opportunistic infections occurring during highly active antiretroviral treatmentC Michelet, C Arvieux, C François, et al.
The Journal of Antimicrobial Chemotherapy|June 8, 2014
Switching from tenofovir/emtricitabine and nevirapine to a tenofovir/emtricitabine/rilpivirine single-tablet regimen in virologically suppressed, HIV-1-infected subjectsC Allavena, E Dailly, V Reliquet, et al.
AIDS (London, England)|February 1, 1997
A prospective study of criteria for the diagnosis of toxoplasmic encephalitis in 186 AIDS patients. The BIOTOXO Study GroupF Raffi, J P Aboulker, C Michelet, et al.
International Journal of STD & AIDS|December 22, 2012
Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescriptionV Colombie, S Pugliese-Wehrlen, S Deuffic-Burban, et al.
L'Encephale|November 14, 2006
[Health related quality of life and lipodystrophy syndrome among HIV-infected patients]M Préau, A-D Bouhnik, B Spire, et al.
Clinical Pharmacology and Therapeutics|July 3, 1999
Safety and efficacy of ritonavir and saquinavir in combination with zidovudine and lamivudineC Michelet, E Bellissant, A Ruffault, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patientsC Michelet, A Ruffault, V Sébille, et al.
Journal of Virological Methods|October 19, 2017
Interest of proviral HIV-1 DNA genotypic resistance testing in virologically suppressed patients candidate for maintenance therapyC Allavena, A Rodallec, A Leplat, et al.
Medecine Et Maladies Infectieuses|April 7, 2009
[Epidemiology of candidemia: a one-year prospective observational study in the west of France]J-P Talarmin, D Boutoille, P Tattevin, et al.
Sexually Transmitted Infections|October 19, 2021
Risk factors for HIV infection among men who have sex with men in the ANRS IPERGAY PrEP trialJulien Gras, Marine Pillet, Guillemette Antoni, et al.
Pageof 23